Hepatic arterial infusion of Floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma

Journal of Surgical Oncology

Volumn 91, Issue 2, 2005, Pages 97-101

  Kemeny, Nancy ^a   Eid, Ahmed ^a   Stockman, Jennifer ^a   Gonen, Mithat ^a   Schwartz, Lawrence ^a   Tetzlaff, Eric ^a   Paty, Philip ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colorectal carcinoma; FUDR; Hepatic arterial infusion; Hepatic metastases; Mitomycin C

Indexed keywords

BILIRUBIN; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACKACHE; BILIRUBIN BLOOD LEVEL; BILOMA; BLOOD TOXICITY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; DUODENUM ULCER; EPIGASTRIC PAIN; FATIGUE; FEMALE; GASTRITIS; GASTROENTERITIS; GASTROINTESTINAL TOXICITY; HEPATIC ARTERY; HUMAN; LEUKOPENIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MYOPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SCLEROSIS; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLOXURIDINE; HEPATIC ARTERY; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LEUKOPENIA; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; RECTAL NEOPLASMS; SURVIVAL RATE; THROMBOCYTOPENIA;

EID: 23044456607     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20286     Document Type: Article

References (23)

1. Ahmedin J, Tiwari R, Murray T, et al.: Cancer Statistics 2004. CA Cancer J Clin 2004;54:8-29.
2. Saltz L, Cox J, Blanke C, et al.: Irinotecan Study Group: Irinotecan plus fluorouracil for metastatic colorectal cancer. N Engl J Med 2000;343:905-914.
3. Goldberg R, Sargent D, Morton R, et al.: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
4. Fong Y, Cohen AM, Fortner JG, et al.: Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946.
5. Breedis C, Young G: The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-977.
6. Ensminger WD, Rosowsky A, Raso V: A clinical pharmacological evaluation of hepatic arterial infusion of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res 1978;38:3784-3792.
7. Kemeny N, Daly J, Reichman B, et al.: Intrahepatic or systemic infusion of FUDR in patients with liver metastases from colorectal carcinoma. Ann Intern Med 1987;107:459-465.
8. Kemeny N, Cohen A, Bertino JR, et al.: Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer 1990;65:2446-2450.
9. Kemeny N, Conti JA, Cohen A, et al.: Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994;12:2288-2295.
10. Kemeny N, Seiter K, Niedzwiecki D, et al.: A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992;69:327-334.
11. Arisawa Y, Sutanto-Ward E, Dalton RR, et al.: Short term intrahepatic FUdR infusion combined with bolus mitomycin C: Reduced risk for developing drug resistance. J Surg Oncol 1994; 56:75-80.
12. Kemeny N, Cohen A, Seiter K, et al.: A randomized trial of hepatic arterial FUDR, Mitomycin-C, and BCNU versus FUDR alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 1993;11:330-335.
13. Borner M, Laffer U, Ludwig C, et al.: Effectiveness and low toxicity of hepatic arterial infusion with fluorouracil and mitomycin-c for metastatic colorectal cancer confined to the liver. Ann Oncol 1990;1:227-228.
14. Sutanto-Ward E, Arisawa Y, Tremiterra S, et al.: Regional chemotherapy for colorectal hepatic metastases: Evidence for improved survival with new drug combinations. Ann Surg Oncol 1996;3: 36-43.
15. Patt YZ, Mavligit GM, Chuang VP, et al.: Percutaneous hepatic arterial infusion (HAI) of mitomycin-c c and floxuridine (fudr): An effective treatment for metastatic colorectal carcinoma in the liver. Cancer 1980;46:261-265.
16. Cohen AM, Kaufman SC, Wood WC: Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy. Dis Colon Rectum 1985;28:389-393.
17. Komatsu M, Fujii T, Goto T, et al.: Giant hepatic biloma following transcatheter oily chemoembolization in a patient with hepatic metastases from malignant pheochromocytoma. Int Med 1998; 37:1034-1038.
18. Sakamoto I, Iwanaga S, Nagaoki K, et al.: Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 2003;181:79-87.
19. Shankar S, vanSonnenberg E, Silverman SG, et al.: Diagnosis and treatment of intrahepatic biloma complicating radiofrequency ablation of hepatic metastases. AJR Am J Roentgenol 2003;181: 475-477.
20. Koda M, Murawaki Y, Mitsuda A, et al.: Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: A randomized control study. Cancer 2001;92:1516-1524.
21. Seno H, Ito K, Kojima K, et al.: Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C. J Gastroenterol Hepatol 1999;XX:811-816.
22. Schneider A, Kemeny N, Chapman D, et al.: Intrahepatic Mitomycin-C as a salvage treatment for patient with hepatic metastases from colorectal carcinoma. Cancer 1989;64:2203-2206.
23. Mortele KJ, Ros PR: Cystic focal liver lesions in the adult: Differential CT and MR imaging features. Radiographics 2001; 21:895-910.